Published in Biochemistry on December 21, 1971
The effects of diphenyleneiodonium on mitochondrial reactions. Relation of binding of diphenylene[125I]iodonium to mitochondria to the extent of inhibition of oxygen uptake. Biochem J (1976) 1.45
Oestrogen receptors in breast cancer: a changing concept. Br Med J (1975) 1.16
Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J (1980) 1.06
Luteinizing hormone receptors: specific binding of human luteinizing hormone to homogenates of luteinized rat ovaries. Proc Natl Acad Sci U S A (1972) 0.98
26-[125I]iodoponasterone A is a potent ecdysone and a sensitive radioligand for ecdysone receptors. Proc Natl Acad Sci U S A (1988) 0.95
Positive cooperativity of the estrogen receptor. Proc Natl Acad Sci U S A (1981) 0.93
Kinetic and physicochemical characteristics of an endogenous inhibitor to progesterone--receptor binding in rat placental cytosol. Biochem J (1981) 0.78
Biological actions of androgens. Endocr Rev (1987) 2.81
Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab (1998) 2.50
Studies on the mechanism of steroid hormone regulation of synthesis of specific proteins. Recent Prog Horm Res (1969) 2.31
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer (1977) 2.02
The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab (1976) 1.92
Specific estrogen binding by the cytoplasm fof human breast carcinoma. J Clin Endocrinol Metab (1970) 1.84
Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Prog Horm Res (1966) 1.74
Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest (1975) 1.60
Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids (1969) 1.57
Evaluation of impotence in older men. West J Med (1985) 1.54
Distribution and natural history of stress fractures in U.S. Marine recruits. Radiology (1983) 1.53
Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule. J Clin Endocrinol Metab (1968) 1.51
Calcium-activated K+ channels as modulators of human myometrial contractile activity. Am J Physiol (1993) 1.44
Pregnancy-related primary brain and spinal tumors. Arch Neurol (1987) 1.44
Isolation and culture of FSH responsive Sertoli cells. Endocr Res Commun (1975) 1.39
A radio-ligand binding assay system for estradiol measurement in human plasma. J Clin Endocrinol Metab (1969) 1.39
Equilibrium and kinetic inhibition assays based upon fluorescence polarization. Methods Enzymol (1981) 1.36
Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J Clin Endocrinol Metab (1974) 1.36
Reporting unethical research behavior. Eval Rev (1999) 1.28
Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer (1980) 1.22
Spinal intramedullary cysticercosis. Neurosurgery (1997) 1.22
Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy. Anticancer Res (1988) 1.18
Oestrogen window hypothesis of the aetiology of breast cancer. Lancet (1980) 1.18
Estrogen stimulation of synthesis of specific proteins and RNA polymerase activity in the immature chick oviduct. Biochim Biophys Acta (1967) 1.16
Measuring consensus about scientific research norms. Sci Eng Ethics (2000) 1.12
Protein kinase translocation as an early event in the hormonal control of uterine contraction. Science (1974) 1.09
Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab (2008) 1.07
Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology. Cancer (1974) 1.06
The endocrinology of breast cancer. Cancer (1980) 1.06
Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab (1974) 1.05
Cultural-sensitivity training in U.S. medical schools. Acad Med (1994) 1.05
Progesterone action: regulation of avidin biosynthesis by hen oviduct in vivo and in vitro. Endocrinology (1968) 1.05
Composition of the Essential Oil of the Leaves of Vitex negundo. Planta Med (1994) 1.04
Experience with cerebellopontine angle epidermoids. Neurosurgery (1997) 1.03
Molecular mechanism of the inhibition of phospholipase C beta 3 by protein kinase C. J Biol Chem (2000) 1.03
An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum Pathol (1993) 1.03
The inactivation of succinate dehydrogenase by bromopyruvate. Biochim Biophys Acta (1971) 1.02
Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. Lab Invest (1978) 1.00
Oxytocin-stimulated responses in a pregnant human immortalized myometrial cell line. Biol Reprod (1996) 1.00
Measurement of plasma LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the short luteal phase. J Clin Endocrinol Metab (1974) 0.99
Use of a modified radioligand assay to measure the effect of estradiol on uterine adenosine 3',5'-cyclic monophosphate. Endocrinology (1973) 0.98
Reversible disaggregation of the cytosol-estrogen binding protein of uterine cytosol. Proc Natl Acad Sci U S A (1968) 0.98
Oxytocin-induced Ca2+ responses in human myometrial cells. Biol Reprod (1999) 0.97
Progesterone receptor in granulosa cell tumor. Gynecol Oncol (1982) 0.97
Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator. Cancer (1990) 0.97
Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cbeta3 stimulation by Galphaq. J Biol Chem (1998) 0.96
Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor. Cancer (1981) 0.96
Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology (1995) 0.96
Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Curr Drug Targets Immune Endocr Metabol Disord (2002) 0.95
Ca(2+)-activated K+ channels in pregnant rat myometrium: modulation by a beta-adrenergic agent. Am J Physiol (1992) 0.95
Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol (1995) 0.94
Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab (1990) 0.94
The endocrinology of the abnormal male breast. Ann N Y Acad Sci (1986) 0.93
Androgen receptor predominance in human ovarian carcinoma. J Steroid Biochem (1987) 0.92
Chromatographic purification of estradiol-17 for use in radio-ligand assay. Biochem Med (1970) 0.91
A radio-ligand assay for plasma estrone; normal values and variations during the menstrual cycle. J Clin Endocrinol Metab (1970) 0.91
Impotence in diabetic men. Am J Med (1988) 0.91
Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc (1988) 0.91
Phosphorylation and regulation of G-protein-activated phospholipase C-beta 3 by cGMP-dependent protein kinases. J Biol Chem (2001) 0.91
Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. Int J Pharm (2004) 0.90
The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology (1980) 0.90
Androgen regulation of the Pem homeodomain gene in mice and rat Sertoli and epididymal cells. J Androl (1998) 0.90
Further studies of gonadotropin and estradiol secretion during the preovulatory phase of the human menstrual cycle. J Clin Endocrinol Metab (1973) 0.90
Protein kinase A anchoring to the myometrial plasma membrane is required for cyclic adenosine 3',5'-monophosphate regulation of phosphatidylinositide turnover. Endocrinology (1999) 0.89
The plasma estradiol as an index of fetoplacental function. J Clin Invest (1971) 0.89
Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen. J Clin Endocrinol Metab (1987) 0.89
Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynecol Oncol (1989) 0.89
Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology (1986) 0.89
Changes in intracellular free calcium in isolated myometrial cells: role of extracellular and intracellular calcium and possible involvement of guanine nucleotide-sensitive proteins. Endocrinology (1989) 0.88
Demonstration of adrenergic catecholamine receptors in rat myometrium and their regulation by sex steroid hormones. Life Sci (1978) 0.88
Progesterone "receptor" in rabbit uterus. I. Characterization and estradiol-17beta augmentation. Endocrinology (1973) 0.88
Antagonism of contractants and relaxants at the level of intracellular calcium and phosphoinositide turnover in the rat uterus. Endocrinology (1989) 0.88
The endometrial adenosine cyclic 3':5'-monophosphate-dependent protein kinase. Distribution, subunit structure, and kinetics of adenosine cyclic 3':5'-monophosphate binding. J Biol Chem (1973) 0.88
The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab (1981) 0.87
Issues in testosterone replacement in older men. J Clin Endocrinol Metab (1998) 0.87
Studies on the mechanism of hormone induction of a specific protein. Immunological identity and kinetic studies of avidin synthesized in vitro by the chick oviduct. Life Sci (1967) 0.87
Functional role for Sp1 in the transcriptional amplification of a cell cycle regulated histone H4 gene. Biochemistry (1995) 0.87
Estrogens and the human male. Annu Rev Med (1976) 0.87
Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease. J Womens Health (Larchmt) (2003) 0.87
Evidence for inhibition by protein kinase A of receptor/G alpha(q)/phospholipase C (PLC) coupling by a mechanism not involving PLCbeta2. Endocrinology (1998) 0.86
An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription. Proc Natl Acad Sci U S A (1994) 0.86
Estrogen and progestogen binding site concentrations in human endometrium and cervix throughout the menstrual cycle and in tissue from women taking oral contraceptives. J Steroid Biochem (1978) 0.86
Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med (1988) 0.85
Correlation of multiple steroid receptors with histological type and grade in human ovarian cancer. Int J Gynecol Pathol (1987) 0.83
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells. J Cancer Res Clin Oncol (1997) 0.83
The effect of relaxin on cyclic adenosine 3',5'-monophosphate concentrations in rat myometrial cells in culture. Endocrinology (1985) 0.83
Adenylate cyclase activation. Characterization of guanyl nucleotide requirements by direct radioligand-binding methods. J Biol Chem (1982) 0.83
Determination of the carboxyl-terminal amino acid residue of the beta-galactosidase of Escherichia coli K 12. Biochim Biophys Acta (1966) 0.83
Erectile dysfunction. J Clin Endocrinol Metab (2001) 0.83
Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3':5'-cyclic monophosphate by oxytocin and prostaglandins. Proc Natl Acad Sci U S A (1972) 0.83
Sertoli cell chromatin acceptor sites for androgen-receptor complexes. J Steroid Biochem (1980) 0.83
Establishment and characterization of an in vitro clonogenic cell assay for the R-3327-At Copenhagen rat prostatic tumor. Cancer Res (1978) 0.83
A role for AKAP (A kinase anchoring protein) scaffolding in the loss of a cyclic adenosine 3',5'-monophosphate inhibitory response in late pregnant rat myometrium. Mol Endocrinol (1999) 0.83
Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer (1994) 0.83
Premature ovarian failure. I: The association with autoimmunity. Eur J Obstet Gynecol Reprod Biol (1989) 0.83